Introduction
Low back pain in humans is associated with intervertebral disc (IVD) degeneration (Cheung et al., 2009; Luoma et al., 2000) . The IVD consists of a hydrated nucleus pulposus (NP), mainly composed of proteoglycan (PG) and collagen type II, circumferentially confined by the annulus fibrosus (AF) in which collagen type I is most prominent. The PG's negative charges attract water into the NP, but its swelling is restricted by the AF. This gives rise to high osmotic pressure, crucial for sustaining compressive loads in the healthy IVD. IVD degeneration is a complex, multifactorial process and is characterised by replacement of proteoglycans and collagen type II by a fibrous and dysfunctional tissue high in collagen type I. Current treatment methods aim to alleviate pain without addressing the underlying mechanism of IVD degeneration. Therefore, FC Bach et al.
Identification of the bioactive factors in NCCM cell-or growth factor-based regenerative strategies have gained increased attention (Bach et al., 2014; Benneker et al., 2014; Sakai and Grad, 2015; Sakai and Andersson, 2015) . Although several regenerative strategies, e.g. allogeneic mesenchymal precursor cell (https:// clinicaltrials.gov/ct2/show/NCT01290367)/autologous disc chondrocyte (NCT01640457) transplantation or growth factor application (NCT00813813), have entered the clinical trial phase, no effective regenerative therapy for IVD degeneration is yet clinically available.
In the field of IVD regeneration, notochordal cells (NCs) have gained increasing interest because of their potential regenerative and protective properties . NCs are large, vacuolated cells and are only present in the NP of foetal and young human individuals. They disappear at approximately 10 years of age, leaving the chondrocyte-like cells (CLCs) as the primary cell type in the NP. This process precedes the onset of IVD degeneration, suggesting that NCs play a role in maintaining tissue health. The regenerative effect of NC-secreted factors present in NC-conditioned medium (NCCM) was demonstrated previously on CLCs (Abbott et al., 2012; Potier et al., 2014) and mesenchymal stem cells (MSCs) (de Vries et al., 2015; Korecki et al., 2010; Purmessur et al., 2011) , with clear cross-species activity (Bach et al., 2015) . Furthermore, porcine NCCM exerted a regenerative effect on bovine NP explants (de Vries et al., 2016) , suggesting that NCCM can also stimulate cells in their native tissue.
The use of NCCM itself, however, is not a clinical option; only small volumes can be injected in the IVD, which is likely insufficient to induce a long-term regenerative response. Therefore, identification and subsequent synthetic production of the biologically active factors in NCCM is more appealing. Up to date, only few studies reported on the potential biologically active NCCM factors. Connective tissue growth factor (CTGF) was found in canine (Erwin et al., 2006) and porcine (Gantenbein et al., 2014) NCCM and alpha-2-macroglobulin, clusterin and tenascin were detected in porcine NCCM (Purmessur et al., 2011) .
Initial identification of NCCM's active factors has focused on proteomics, but extracellular vesicles (EVs) have not been considered yet. EVs are a heterogeneous group of small, membrane-enclosed particles (~40 nm to ~5 µm), actively released by cells from various tissue types (van der Vlist et al., 2012; Witwer et al., 2013) . EVs play an active role in intercellular signalling, since they can express receptor ligands or can be vehicles of signalling molecules. Previous studies indicated that EVs influence various processes, such as pathogenesis of diseases (Anderson et al., 2010) and tissue regeneration (Malda et al., 2016) . As such, it was hypothesised that EVs can also be secreted by NCs and may be involved in maintaining healthy NP tissue. The aim of the current study was to identify whether soluble (peptides and proteins) or pelletable (protein aggregates and EVs) factors are responsible for the anabolic effects of NCCM on CLCs. We hypothesised that both the soluble and pelletable factors contribute to the anabolic effects of NCCM.
Materials and Methods

Sources of NC-rich NP tissue and generation of NCCM
Thompson grade I IVDs were collected from 5 porcine, 16 canine and 3 human donors. Porcine spines (3 months of age, C1-S1) were collected from the local abattoir. Canine spines (16-38 months of age, C1-S1) were collected from mixed breed non-chondrodystrophic (NCD) dogs euthanised in unrelated research studies, approved by the Utrecht University Animal Ethics Committee. IVDs from human donors (L2-L5) between 20 weeks of gestation and 2 days of age (postnatal) were obtained during standard post mortem diagnostic procedures, approved by the scientific committee of the Pathology Department of the University Medical Centre Utrecht. Anonymous use of redundant tissue for research purposes is a standard treatment agreement with patients in the University Medical Centre Utrecht (Local Medical Ethical Committee (METC) number 12-364). The material was used in line with the code 'Proper Secondary Use of Human Tissue' installed by the Federation of Biomedical Scientific Societies.
Generation of NCCM
Conditioned medium from porcine (n = 5), canine (n = 8) and human (n = 3) NC-rich NP tissue (NCCM+) was generated by culturing NP tissue for 4 d (1 g tissue/30 mL) in hgDMEM+Glutamax (31966, Invitrogen, Paisley, UK) with 1 % penicillin/streptomycin (P11-010, GE Healthcare Life Sciences, Eindhoven, the Netherlands) at 37 °C, 5 % CO 2 and 5 % O 2 (Bach et al., 2015) ( Fig. 1a ). After 4 d, NP tissue was removed and NC-conditioned medium was filtered through 70 µm cell strainers. The filtrate was sequentially centrifuged at 200×g and 500×g (two times 10 min, 4 °C) to remove (dead) cells and debris. Thereafter, the supernatant (cell-free conditioned medium) was concentrated using a 3 kDa Amicon Ultra-15 Centrifugal filter tube (Merck Millipore, Amsterdam, the Netherlands) at 4000×g (45 min, 4 °C). All substances with a molecular weight >3 kDa were resuspended in fresh hgDMEM+Glutamax and stored in aliquots at −70 °C until use. To determine whether the porcine and canine NCCM+ effects were NC-specific, negative control conditioned media (NCCM−) were generated by re-culturing the NP tissue in the presence of 5 % foetal bovine serum (FBS, Gibco 16000-044, Life Technologies, Bleiswijk, the Netherlands); the latter results in loss of vacuolated-NC morphology . NP tissue was cultured for 18 d with medium changes twice a week, until no more vacuoles were observed. Subsequently, the NP tissue was washed twice to remove FBS components, and cultured for 4 d in hgDMEM+Glutamax with 1 % P/S to generate NCCM−. NCCM− was centrifuged, filtered and stored similar to NCCM+. et al., 2013) . Thereafter, in order to yield NCCM-P, 6.7 µL of the 100,000×g pellet was added to 1 mL basal culture medium (hgDMEM+Glutamax with 1 % P/S, 1 % ITS+ premix (354352, Corning Life Sciences, Amsterdam, the Netherlands), 0.04 mg/mL L-proline (P5607, Sigma-Aldrich), 0.1 mM ascorbic acid 2-phosphate, and 1.25 mg/mL BSA. The EV content of NCCM-P was hereby similar to NCCM+.
Proteomic analysis of porcine, canine and human
Biochemical analysis of NCCM and its fractions
The protein concentration of NCCM+, NCCM−, NCCM-S and NCCM-P (porcine n = 4, canine n = 8) was assessed using the Qubit ® Protein Assay Kit (Q33211, Invitrogen) according to the manufacturer's instructions. In addition, a dimethyl methylene blue (DMMB) assay (Farndale et al., 1982) was performed to determine the glycosaminoglycan (GAG) concentration.
In vitro culture of bovine and canine CLCs in pelletable and soluble fractions of NCCM
Bovine CLCs (n = 4 repeats, CLCs from 2 donors pooled per repeat, 2-2.5 years of age, Thompson grade II) were harvested from caudal IVDs obtained from the local abattoir, and chondrodystrophic (CD) canine CLCs (n = 4, 3-10 years of age, Thompson grade III) were harvested from IVDs of dogs euthanised in unrelated research studies, approved by the Utrecht University Animal Ethics Committee. NPs were enzymatically digested with 0.1 % pronase (10165921001, Roche Diagnostics, Almere, the Netherlands) for 90 min and subsequently with 0.025 % collagenase type II (LS004177, Worthington, Lakewood, NJ, USA) for 16 h at 37 °C. Bovine CLCs were suspended in 1.2 % alginate (180947, Sigma-Aldrich) beads of approximately 20 µL at 3 × 10 6 cells/mL (Guo et al., 1989) . Empty (no cellcontaining) and CLC-containing beads were cultured for 28 d at 37 °C, 5 % CO 2 and 5 % O 2 in basal medium or in porcine NCCM+, NCCM−, NCCM-S or NCCM-P (four different porcine NCCM donors), each with the same supplements as basal culture medium.
Given that canine CLCs did not thrive in alginate beads (Arkesteijn et al., 2015) , an albumin-based hydrogel was used (Scholz et al., 2010) . Canine CLCs from four donors were pooled to assess the effect of donor-specific NCCM on a representative canine CLC population.
Passage 2 CLCs were incorporated in 40 µL hydrogels composed of chemically activated albumin cross-linked by polyethylene glycol spacers (3 × 10 6 cells/mL hydrogel). The albumin-and hyaluronic acidcontaining hydrogels were cultured for 28 d at 37 °C, 5 % CO 2 and 5 % O 2 in basal culture medium with/without 10 ng/mL transforming growth factor-β 1 (TGF-β 1, 240-B, R&D Systems, Minneapolis, MN, USA), or in canine NCCM+, NCCM−, NCCM-S or NCCM-P (eight different canine NCCM donors), each with the same supplements as basal medium. Unlike bovine CLCs, canine CLCs do not produce a considerable amount of GAGs if no growth factor is supplemented to the culture medium. Therefore, a positive control (10 ng/mL TGF-β 1 ) was used to show that the canine CLC donors were able to produce GAGs if a proper stimulus was provided, e.g. in case these donors would not respond to NCCM. Since the hydrogel bound GAGs present in NCCM, empty hydrogels were cultured along for each NCCM−/NCCM+/NCCM-S/NCCM-P donor to be able to correct for this.
Gene expression profiling (RT-qPCR; canine n = 8) was performed at day 4, the DNA content (dsDNA High Sensitivity Assay Kit, Q32851, Invitrogen) and GAG content (DMMB assay; porcine NCCM-treated bovine CLCs n = 4 and canine NCCM-treated canine CLCs n = 8 in duplo) were determined at days 0 and 28, and Safranin O/Fast Green staining and collagen type I and II immunohistochemistry (porcine NCCM-treated bovine CLCs n = 3-4 and canine NCCM-treated canine CLCs n = 4-8) were performed at day 28 (Bach et al., 2015) . For gene expression profiling, four reference genes (GAPDH, HPRT, RPS19 and SDHA) were chosen to normalise gene expression of the target genes ACAN, ADAMTS5, BAX, BCL-2, CASP3, COL1A1, COL2A1, COL10A1, CCND1, FOXF1, KRT8, KRT18, KRT19, MMP13, T and VEGF. Primer sequences are depicted in Table 1 . The DMMB assay was done with the following modifications: papain and DMMB solution pH was adjusted to 6.8 and guanidinium chloride was used to mask hyaluronic acid.
Testing fresh versus frozen pelletable NCCM factors in vitro
To determine whether freezing the pelletable factors affected their biological effect, micro-aggregates of 35,000 CD canine CLCs were generated (Bach et al., 2015) . CLCs have more easy access to the pelletable factors in this culture model compared with hydrogels. The micro-aggregates were cultured in low-adherence 96-well plates (650970, CELLSTAR ® , Greiner Bio-one, Alphen a/d Rijn, the Netherlands) at 37 °C, 5 % CO 2 and 5 % O 2 for 7 d and were treated with basal culture medium (control), freshly generated, non-frozen NCCM-P (P1x fresh; kept at 4 °C for maximum 4 d) or canine NCCM-P that was frozen at −70 °C for maximum 4 d (P1x frozen).
To determine whether a higher concentration pelletable factors would exert a more pronounced effect, fresh and frozen pelletable factors were also applied in a 10× higher concentration than present in NCCM+ (NCCM-P10× fresh and NCCM-P10× frozen, respectively). The same CD canine CLC donors as used in the hydrogel experiment and 4 different NCD canine NCCM donors were used for FC Bach et al.
Identification of the bioactive factors in NCCM Fig. 4 . Only the soluble factors present in canine NC-conditioned medium (NCCM) stimulate expression of genes related to cell proliferation of canine chondrocyte-like cell (CLC), but none of the NCCM (fractions) effects expression of genes related to matrix production. Target gene expression levels of canine CLCs cultured in hydrogels in basal culture medium (control), basal culture medium supplemented with 10 ng/mL TGF-β 1 , NCCM from dedifferentiated NCs (NCCM−), NCCM from healthy NCs (NCCM+), and the soluble (NCCM-S) and pelletable (NCCM-P) fraction of NCCM+, which were separated by ultracentrifugation. (a-k) Relative ACAN, COL1A1, COL2A1, ADAMTS5, MMP13, CCND1, KRT8, KRT18, KRT19, FOXF1, and VEGF gene expression (mean ± SD) of the hydrogels at day 4. The control hydrogels were set at 1. a, significant difference between this condition and all other conditions (p < 0.05); b, significant difference between this condition and all other conditions except control (p < 0.05); c, significant difference between these conditions (p < 0.05); d, significant difference between this condition and all other conditions (p < 0.01); e, significant difference between this condition and all other conditions except NCCM-P (p < 0.05); n = 8.
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GAG concentration of canine NCCM+ and NCCM-S was significantly higher than that of NCCM− and NCCM-P, whereas the protein and GAG concentration of NCCM-P was significantly lower than that of NCCM− (p < 0.001, Fig. 3a ). After 4 d of culture, gene expression profiling was performed on the canine CLC-containing hydrogels and after 28 d of culture, the hydrogels were analysed for DNA and GAG content and histology. The DNA content and CCND1 (a marker for cell proliferation) expression of the TGF-β 1 -treated hydrogels was significantly increased compared with all other conditions (p < 0.05, Figs. 3b  and 4f ). Furthermore, NCCM+ and NCCM-S-treated hydrogels showed a significantly increased DNA content compared with controls, and NCCM+ treatment showed a significantly increased DNA content compared with NCCM-P and NCCM− treatment (p < 0.05, Fig. 3b ). CCND1 expression was significantly lower in NCCM-Ptreated CLCs than in NCCM−/NCCM+/NCCM-S-treated CLCs (p < 0.05, Fig. 4f ).
Using the DMMB assay, empty (no cell-containing) hydrogels were found to incorporate a large amount of NCCM-derived GAGs, indicated by the grey bars in Fig. 3c . The GAG content of the control hydrogels was significantly lower than that of all other conditions (p < 0.001, Fig. 3c ). TGF-β 1 , NCCM+ and NCCM-S treatment induced the highest total GAG content of the CLC-containing hydrogels: significantly higher than after NCCM− and NCCM-P treatment (p < 0.001, Fig. 3c ). The GAG content of the NCCM-P-treated hydrogels was significantly lower than that of the hydrogels treated with NCCM− (p < 0.01, Fig.3c ). The total GAG/DNA content of NCCM+ and NCCM-S-treated hydrogels was the highest, followed by hydrogels treated with TGF-β 1 , NCCM−, NCCM-P and basal culture medium, respectively (p < 0.05, Fig. 3d ). Safranin O/Fast Green staining indicated that most GAGs were deposited in the TGF-β 1 -treated hydrogels, followed by NCCM+ and NCCM-S-treated hydrogels (Fig. 3e ). Collagen type I deposition was only induced by TGF-β 1 treatment, not by NCCM fractions (Fig.  3e ). Collagen type II was mostly deposited in NCCM+, NCCM-S, and TGF-β 1 -treated hydrogels, but also some collagen type II was present in NCCM-P-treated hydrogels (Fig. 3e) . Affirmatively, at the gene expression level, TGF-β 1 treatment significantly induced ACAN, COL1A1 and COL2A1 mRNA compared with all other conditions (p < 0.05, Fig. 4a-c) . In contrast, NCCM (fractions) did not influence COL2A1 expression compared with controls ( Fig.  4a-c ). NCCM-P inhibited ACAN expression and NCCM− and NCCM+ induced COL1A1 expression compared with controls (p < 0.05, Fig. 4a-c) . COL10A1 expression was not detected in any condition (data not shown).
Furthermore, TGF-β 1 treatment significantly reduced ADAMTS5 expression compared with all other conditions, whereas NCCM− significantly induced ADAMTS5 expression compared with controls and NCCM-P (p < 0.05, Fig. 4d ). NCCM+ induced even more ADAMTS5 expression than NCCM− and NCCM-S increased ADAMTS5 expression compared with NCCM-P (p < 0.05, Fig. 4d ). MMP13 expression was significantly decreased by TGF-β 1 treatment compared with controls, whereas NCCM-S reduced MMP13 expression compared with controls, NCCM+ and NCCM-P (p < 0.05, Fig. 4e ). Expression of the notochordal marker T was not detected regardless of the culture condition (data not shown), whereas expression of notochordal marker KRT8 was significantly higher in micro-aggregates treated with NCCM+ than in micro-aggregates treated with NCCM-P, NCCM−, TGF-β 1 and the negative controls (p < 0.05, Fig.  4g ). Expression of NP marker KRT18 was significantly increased in micro-aggregates treated with basal culture medium, NCCM+, NCCM-S and NCCM-P compared with TGF-β 1 -treated micro-aggregates (p < 0.05, Fig. 4h ). KRT19 expression was significantly increased by NCCM-P and NCCM-S treatment compared with controls (p < 0.05, Fig. 4i ). Additionally, NCCM+, NCCM-S and NCCM-P treatment significantly increased the expression of this NP marker compared with NCCM− and TGF-β 1 treatment (p < 0.05, Fig.4i ). In contrast, FOXF1 expression was not influenced by the culture conditions (Fig. 4j) . Expression of the angiogenic marker VEGF was significantly higher in micro-aggregates treated with NCCM− than in all other conditions (p < 0.05, Fig. 4j ). Furthermore, VEGF expression was significantly decreased by NCCM-P treatment compared with control, TGF-β 1 and NCCM-S treatment (p < 0.05). Apoptosis-related genes (BAX, BCL2, CASP3) were not differentially expressed between the conditions (data not shown).
Fresh versus frozen pelletable factors present in canine NCCM
Gene expression profiling of CD canine CLC microaggregates cultured in basal culture medium (control), 1× concentrated fresh (non-frozen) and frozen NCCM-P and 10× concentrated fresh (non-frozen) and frozen NCCM-P was performed at day 4. Due to donor variability, high standard deviations were obtained (Fig. 5a) . At day 7, the DNA content of all micro-aggregates was significantly decreased compared with day 0 (p < 0.01, Fig 5b) . The GAG and GAG/DNA content of the controls was significantly lower than that of the micro-aggregates treated with 1× and 10× concentrated NCCM-P (p < 0.01, Fig  5b) . Moreover, the GAG and GAG/DNA content of the micro-aggregates treated with 10× concentrated NCCM-P was significantly higher than that of the micro-aggregates treated with 1× concentrated NCCM-P (p < 0.01, Fig 5b) , indicating a concentration-dependent effect, which could be repeated with frozen NCCM-P. This indicates that freezing the pelletable factors for a short period (1 h -4 d) at −70 °C in EV-depleted PBS/0.2 % BSA did not affect their biological effect.
Discussion
NCCM exerts cross-species anabolic effects on CLCs
Porcine, canine and human NC-secreted factors have already shown potential for IVD regeneration (Abbott et al., 2012; Bach et al., 2015; de Vries et al., 2016; Gantenbein et al., 2014; Korecki et al., 2010; Purmessur et al., 2011) . With a clinical directive in mind, the aim of this study was to delineate underlying bioactive NC-secreted substances (with the focus on proteins and EVs) resulting in IVD regeneration. The present study shows that porcine and canine NCCM+ have the potential to exert a regenerative effect on bovine and canine CLCs, respectively. Secreted factors from healthy NCs (NCCM+) exerted a more pronounced anabolic effect and induced higher notochord/ nucleus pulposus specific marker expression in CLCs than the secreted factors from dedifferentiated NCs (NCCM−), indicating that this was related to preservation of the NC phenotype (Arkesteijn et al., 2013) .
Proteomic analysis reveals many common proteins in porcine, canine and human NCCM
Since previous findings indicated regenerative effects of porcine, canine and human NCCM on human CLCs (Bach et al., 2015) , the main focus of the proteomic analysis of this study was on common proteins discovered in NCCM from all three species. A considerable part of the detected proteins consisted of ECM, e.g. proteoglycans, collagens and keratins, and organelle-derived proteins. However, specific growth factors, potentially responsible for NCCM's regenerative effect, were not identified, which is in contrast with previous studies in which CTGF was identified in canine (Erwin et al., 2006) and porcine (Gantenbein et al., 2014) NCCM. This discrepancy may be due to the method of NCCM generation. Whereas the previous studies produced NCCM from isolated NCs, in the current study, NCCM was generated from NC-rich NP tissue. Potential growth factors secreted by NCs may therefore be overshadowed by large quantities of proteins released during NP tissue incubation. In line with previous findings (Purmessur et al., 2011) , however, clusterin and alpha-2-macroglobulin were detected in all the species' NCCM, and tenascin in human and canine NCCM. These matricellular proteins may have protective effects for NP cells. Furthermore, class 3 semaphorins were identified in canine (SEMA3C, SEMA3E) and porcine (SEMA3C) NCCM. SEMA3C is suggested to play a role in innervation and vascularisation of degenerated human IVDs and has been linked to back pain (Binch et al., 2015) . The finding of SEMA3C and SEMA3E in canine and porcine NCCM derived from healthy NPs, however, may also support an inhibitory role of semaphorins in nerve and blood vessel growth (Bagnard et al., 1998) .
The proteins in common to all three species and upstream bioinformatics analysis provide new insights into IVD (patho)physiology, including transcriptional gene regulation. For example, proteins related to transcription factor binding sites AP-1 and PAX4 were identified. AP-1 is a downstream target of the mitogenic activated protein (MAP) kinase signalling pathway and regulates chondrogenic differentiation (Seghatoleslami and Tuan, 2002) . In healthy porcine, canine and human NP tissue, GAG synthesis may be regulated in an AP-1/growth factor-dependent manner, given that BMP2 and TGF-β induced the expression of the GAG synthesis enzyme β1,3-glucuronosyl transferase 1 in rat NP cells viaamongst others -AP-1 (Hiyama et al., 2010) . PAX4 has been mainly studied in the pancreas (Mathiyalagan et al., 2015; Napolitano et al., 2015) , whereas its role in bone/ cartilaginous tissues is unexplored. PAX1 and PAX9, however, are known to be associated with axial and limb skeleton development (LeClair et al., 1999) and vertebral body and cartilage formation (Barnes et al., 1996) . Furthermore, the current study also demonstrates that proteins related to miR-29a/b/c were present in porcine and human NCCM+. The miR-29 family negatively regulates TGF-β and canonical Wnt signalling Luna et al., 2011) , exerts anti-fibrotic effects (He et al., 2013) , and acts across development and progression of osteoarthritis . In the IVD, the role of the miR-29 family has not been investigated yet, but based on knowledge from other tissues it could also be involved in ECM production.
Taken together, many common proteins were identified in porcine, canine and human NCCM. Mainly ECM and organelle-derived proteins, but no specific growth factors were detected. Furthermore, in porcine and human NCCM, platelet-and complement system-related proteins were identified. Possibly these proteins were identified as a result of blood contamination explained by the technically challenging harvesting of NP tissue, rather than being a biologically relevant finding. Hence, it may be beneficial for future studies to focus on comparative proteomic analysis of porcine, canine and human NCCM generated from isolated NCs, without interfering ECM proteins.
Pelletable NCCM factors exert a moderate anabolic effect on canine CLCs
Proteomic analysis revealed that NCCM+ contained a considerable amount of membrane-bound vesicle proteins. In functional studies, the effect of NCCM-P (containing EVs and protein aggregates) was determined on CLCs. In bovine CLCs, the effect of porcine NCCM-P factors was negligible. In contrast, canine NCCM-P factors increased, in a concentration-dependent manner, the canine CLC GAG, GAG/DNA and collagen type II content compared with controls (although less pronounced than for the soluble factors). Also, canine NCCM-P decreased VEGF and increased KRT19 expression compared with controls, indicating that it inhibited angiogenesis (Cornejo et al., 2015) and induced a healthy NP-like phenotype (Minogue et al., 2010) . The bovine CLCs were obtained from relatively healthy/early degenerated IVDs and the canine CLCs from degenerated IVDs, which may explain the difference in response, besides NCCM/CLC species differences.
In the present study, NCCM-P needed to be frozen, since canine NCCM donors were available at unpredictable moments. The effect of freezing EVs is controversial: previous studies demonstrated that EVs were relatively insensitive to freeze/thaw cycles (Lorincz et al., 2014; Witwer et al., 2013) , whereas others showed the opposite (Dey-Hazra et al., 2010) . The current study showed that at least 4 d of freezing at −70 °C did not influence the biological activity of canine NC-derived pelletable factors compared with non-frozen pelletable factors (kept at 4 °C) from the same donor on canine CLC micro-aggregates. Besides long term freezing, also relatively hampered access to the pelletable factors could have accounted for the less FC Bach et al.
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Taken together, the present study demonstrates that the NCCM-P factors (protein aggregates and EVs) exerted a moderate concentration-dependent anabolic effect, but only on canine CLCs. While we cannot exclude that the absence of a biologic effect of EVs present in the NCCM-P may be related to the 100,000×g ultracentrifugation (Nordin et al., 2015) , future studies should focus on the effect of different isolation protocols and different populations of purified NC-derived EVs, without interference of protein aggregates present in NCCM-P.
Soluble porcine and canine NCCM factors exert anabolic effects on bovine and canine CLCs
It appeared that most proteins remained in the soluble fraction of canine and porcine NCCM after ultracentrifugation. The effect of porcine NCCM-S on bovine CLCs was similar to that of NCCM+, suggesting that porcine NCCM exerted its anabolic effect mainly through protein-based mechanisms. Also in the canine species, and the GAG content of NCCM-S-treated hydrogels was rather similar to that of hydrogels treated with NCCM+. However, the hydrogel appeared to have the propensity to bind the GAGs present in NCCM.
Correcting for this property indicates that NCCM− may be even more active than NCCM+ or NCCM-S. However, this was not evident from the histological analysis. In our view, the amount of GAGs produced by the CLCs themselves cannot simply be calculated by correcting for the GAG content of empty hydrogels cultured in NCCM, because the incorporated ECM proteins likely changed the microenvironment and consequently affected GAG synthesis (Gilchrist et al., 2011; Inoue et al., 2005) .
Generally, notochord/nucleus pulposus specific marker expression was higher after NCCM+ and NCCM-S than after NCCM-P treatment, indicating that NCCM+ and NCCM-S were better able to induce a healthy NP phenotype. Furthermore, ACAN and COL2A1 expression did not differ between NCCM-treated CLCs and controls, while ADAMTS5 and MMP13 gene expression levels were generally higher in NCCM+ and/or NCCM-Streated CLCs compared with other conditions. The latter is most probably related to ECM remodelling rather than catabolism, given that histological analysis points towards a stronger anabolic effect of NCCM+ and NCCM-S than NCCM-P and NCCM−. In NCCM+ and NCCM-S, more pericellular GAGs were observed, suggesting that the CLCs synthesised these GAGs themselves. Also collagen type II deposition was highest after NCCM+ and NCCM-S treatment, again indicating that both porcine and canine NCCM exerted their anabolic effects mainly through proteins. Since no blocking experiment was performed, however, it is difficult to discern if one or combination of factors are responsible for the effects of NCCM.
Conclusions
The present study demonstrates an anabolic cross-species effect of porcine and canine NCCM+ on bovine and canine CLCs, respectively. Especially on bovine CLCs, a pronounced effect of the soluble NCCM fraction (NCCM-S; peptides, proteins) was found, without an appreciable effect of the pelletable NCCM fraction (NCCM-P; protein aggregates, EVs). However, NCCM-P exerted a moderate anabolic effect on canine CLCs, although the culture system used precludes firm conclusions. Thus, although porcine and canine NCCM exerted their anabolic effects mainly through soluble factors, also the pelletable NCCM factors showed moderate regenerative potential. Although the regenerative potential of NCCM-P should not be overlooked, future studies should focus on unravelling the protein-based regenerative mechanism from NCCM produced from isolated NCs, e.g. by NCCM fractionation and pathway blocking studies.
